Related Experiment Video
Updated: May 24, 2026
07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
Treatment Options in Cushing's Disease.
Ahmed Rizk1, Juergen Honegger, Monika Milian
1Department of Neurosurgery, University of Tuebingen, Germany.
Clinical Medicine Insights. Oncology
|February 21, 2012
Summary
Cushing's disease, often caused by pituitary tumors, requires individualized treatment. Surgery is primary, with medical therapy and adrenalectomy as crucial second-line options for managing hormone excess and comorbidities.
Area of Science:
- Endocrinology
- Oncology
- Neurosurgery
Background:
- Endogenous Cushing's syndrome is a severe condition characterized by excessive cortisol production.
- Cushing's disease, caused by pituitary adenomas secreting ACTH, accounts for 80% of cases.
- Treatment aims to normalize hormone levels, achieve long-term control, and reverse associated comorbidities.
Purpose of the Study:
- To review and analyze current treatment strategies for Cushing's disease.
- To discuss the role of neurosurgery, medical therapy, and bilateral adrenalectomy.
- To highlight individualized treatment approaches for patients with Cushing's syndrome.
Main Methods:
- Literature review of current treatment options for Cushing's disease.
- Analysis of first-line and second-line therapeutic modalities.
- Discussion of drug targets, surgical outcomes, and adrenalectomy implications.
Main Results:
- Neurosurgical tumor removal is the primary treatment for Cushing's disease.
- Second-line options include medical therapy, bilateral adrenalectomy, and radiation therapy.
- Medical therapies target hormone production or action, while adrenalectomy offers immediate control but requires lifelong hormone replacement.
Conclusions:
- Treatment for Cushing's syndrome necessitates a multidisciplinary and individualized approach.
- Surgery is the preferred initial treatment, but medical management and adrenalectomy are vital for persistent or severe cases.
- Careful patient evaluation is essential for selecting the optimal treatment strategy, balancing efficacy with potential risks and side effects.
Related Concept Videos
01:26Cushing Syndrome I: Introduction
Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:27Adrenal Gland Disorders
Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Chronic Pancreatitis II: Collaborative Care
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation